JUMP REPORT
| Avg Daily Volume: 1,175,032 Market Cap: 3.66B Sector: Technology Short Interest: 8.58 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .35/share REV: 85.3/M
___________________________________________________________
LAST QTR: EPS: .33/share ACTUAL: .41/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .31/share REV: 83.9/M
______________________________________________________
FULL YR: EPS: 1.33/share REV: 343.3/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 91% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 4.89, -4.06, -13.75
POTENTIAL JUMP MOVE: 8-10%
Links To Latest News and Headlines
HQY’s growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.
HealthEquity’s 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.
HealthEquity (NASDAQ:HQY) posted second-quarter fiscal 2027 results on August 27, which pushed revenue growth to 8% year over year, up from the 7% pace set over the first half of the year, a rare acceleration for a company already sitting on 10.7 million health savings accounts/HSAs. Adjusted EBITDA jumped 11% to $167 million, translating into […]
Record profitability and accelerated invested asset growth signal durability.
Sales and earnings beats in fiscal Q2 weren’t enough to satisfy investors.
StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.